Clean Power Hydrogen Posting of Annual Report and Notice of AGM

RNS Number : 8629N

Clean Power Hydrogen

10 May 2024

 

 

10 May 2024

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

Posting of Annual Report and Notice of Annual General Meeting

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), announces that the Company's 2024 Annual General Meeting ("AGM") will be held at The Royal Suite, Doncaster Racecourse, Leger Way, Doncaster, DN2 6BB at 11.00am on Wednesday 19 June 2024. The Notice of AGM has been posted to shareholders and is available on the Company's shareholders website at www.cph2.com/investors/financial-calendar.

 

The Company's 2023 Annual Report, has also been posted to shareholders and is available on the Company's website at https://www.cph2.com/investors/annual-interim-reports.

 

 

For more information, please contact:

 

Clean Power Hydrogen plc	via Camarco
Jon Duffy, Chief Executive Officer James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald	[phone]
Peter Lynch	[phone]
Adam Rae	[phone]
Camarco PR	+ 44(0) 20 3 757 4980
Billy Clegg
Owen Roberts
Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NOAQKCBQQBKDCPK